TEVA PHARMACEUTICAL INDUSTRIES LTD — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
20-F
25
3
3/A
4
4/A
40-F
424B3
424B5
425
5
6-K
6-K/A
8-A12B
8-K
ARS
CERTNYS
CORRESP
DEF 14A
DEFA14A
EFFECT
F-3
F-3/A
F-3ASR
F-4
F-4/A
F-4MEF
F-6
F-6 POS
F-6EF
FWP
POS AM
POSASR
PRE 14A
S-3
S-3/A
S-3ASR
S-4
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14D1
SC 14D1/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144/A | — | 0001973379-26-000039 | Feb 18, 2026 | — |
| SCHEDULE 13G | — | 0001178913-26-000521 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001178913-26-000330 | Feb 9, 2026 | — |
| 10-K | 10-K | 0001193125-26-034532 | Feb 3, 2026 | Dec 31, 2025 |
| 4 | 4 | 0001193125-26-029337 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | 4 | 0001193125-26-029312 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | 4 | 0001193125-26-029329 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | 4 | 0001193125-26-029300 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | 4 | 0001193125-26-029306 | Jan 29, 2026 | Jan 27, 2026 |
| 8-K | FORM 8-K | 0001171843-26-000462 | Jan 28, 2026 | — |
| 8-K | FORM 8-K | 0001171843-26-000174 | Jan 12, 2026 | Jan 11, 2026 |
| 4 | 4 | 0001193125-25-324780 | Dec 18, 2025 | Dec 16, 2025 |
| 4 | 4 | 0001193125-25-324789 | Dec 18, 2025 | Dec 16, 2025 |
| 144 | — | 0000902664-25-005281 | Dec 12, 2025 | — |
| 4 | 4 | 0001193125-25-315923 | Dec 11, 2025 | Dec 9, 2025 |
| 4 | 4 | 0001193125-25-315938 | Dec 11, 2025 | Dec 9, 2025 |
| 8-K | 8-K | 0001193125-25-316063 | Dec 11, 2025 | Dec 10, 2025 |
| 144 | — | 0001973379-25-000316 | Dec 9, 2025 | — |
| 144 | — | 0001973379-25-000315 | Dec 9, 2025 | — |
| 4 | 4 | 0001193125-25-308057 | Dec 4, 2025 | Dec 2, 2025 |
| 4 | 4 | 0001193125-25-303849 | Dec 1, 2025 | Nov 26, 2025 |
| 144 | — | 0000902664-25-005163 | Nov 26, 2025 | — |
| 4 | 4 | 0001193125-25-293655 | Nov 24, 2025 | Nov 20, 2025 |
| 144 | — | 0001973379-25-000296 | Nov 20, 2025 | — |
| 4 | 4 | 0001193125-25-286134 | Nov 18, 2025 | Nov 14, 2025 |
| 144 | — | 0001973379-25-000292 | Nov 14, 2025 | — |
| 4 | 4 | 0001193125-25-274286 | Nov 10, 2025 | Nov 6, 2025 |
| 4 | 4 | 0001193125-25-274204 | Nov 10, 2025 | Nov 6, 2025 |
| 144/A | — | 0000902664-25-004764 | Nov 6, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-266895 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001171843-25-007000 | Nov 5, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002871 | Nov 5, 2025 | — |
| SCHEDULE 13G | — | 0001178913-25-003465 | Oct 6, 2025 | — |
| 144 | — | 0000902664-25-004073 | Sep 12, 2025 | — |
| 4 | 4 | 0000950170-25-113800 | Sep 9, 2025 | Sep 5, 2025 |
| SCHEDULE 13G/A | — | 0000315066-25-002100 | Aug 6, 2025 | — |
| 4 | 4 | 0000950170-25-102992 | Aug 5, 2025 | Aug 1, 2025 |
| 4 | 4 | 0000950170-25-102977 | Aug 5, 2025 | Aug 1, 2025 |
| 144 | — | 0001973379-25-000209 | Aug 1, 2025 | — |
| 144 | — | 0001973379-25-000208 | Aug 1, 2025 | — |
| 8-K | FORM 8-K | 0001171843-25-004808 | Jul 30, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-169296 | Jul 30, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | — | 0001178913-25-002442 | Jul 22, 2025 | — |
| SCHEDULE 13G | — | 0001178913-25-002400 | Jul 17, 2025 | — |
| 4 | 4 | 0000950170-25-086697 | Jun 16, 2025 | Jun 12, 2025 |
| 144 | — | 0001973379-25-000186 | Jun 12, 2025 | — |
| 4 | 4 | 0000950170-25-083756 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083765 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083769 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | 4 | 0000950170-25-083777 | Jun 9, 2025 | Jun 5, 2025 |